Mitra Vikramjit, Mitchison Harriet, Nylander David
Specialist Registrar in Gastroenterology, Sunderland Royal Hospital, UK.
Consultant Gastroenterologist, Sunderland Royal Hospital, UK.
Frontline Gastroenterol. 2012 Jul;3(3):152-156. doi: 10.1136/flgastro-2011-100084. Epub 2012 Apr 27.
Endoscopic retrograde cholangio-pancreatography (ERCP) is an important tool in the management of pancreato-biliary disease.
To compare the current practice of ERCP in a district general hospital with those reported in the 2007 British Society of Gastroenterology (BSG) ERCP audit and assess access to the service.
This was a service evaluation study. Data were collected retrospectively for all people who underwent ERCP. Demographic, clinical and procedure related data were collected and analysed.
Sunderland Hospital.
236 patients (median age 70 years, 56% women) underwent ERCP. The median period from referral to patient review was 1.0 day. The median period from the decision to carry out an ERCP to the actual procedure date was 3 days. All patients had radiological imaging before their first procedure. 96% patients had their bloods checked within 1 week of the procedure. The most common indication was related to choledocholithiasis and its complications. The mean doses of midazolam and diazemul used were 4.4 mg and 11.1 mg, respectively. The selective biliary cannulation rate was 92%. Sphincterotomy, biliary stent insertion and complete stone extraction were achieved in 94%, 85% and 88% of patients before the procedure. Complications that occurred as a result of ERCPs were as follows: bleeding (1.7%), pancreatitis (3.8%), cholangitis (0.4%) and renal failure (0.4%). The 30-day death rate was 4.6%. However, none of these were procedure related.
The structure of the ERCP services at Sunderland Royal Hospital provides patients with a high-quality and accessible service. The technical success rate and sedation rate were better than those reported in the BSG ERCP audit. The complication rate and procedure-related mortality were comparable to the BSG audit and much below the published figures.
内镜逆行胰胆管造影术(ERCP)是诊治胰胆疾病的一项重要手段。
比较一家地区综合医院当前的ERCP操作情况与2007年英国胃肠病学会(BSG)ERCP审核报告中的情况,并评估该服务的可及性。
这是一项服务评估研究。对所有接受ERCP的患者进行回顾性数据收集。收集并分析人口统计学、临床及与操作相关的数据。
桑德兰医院。
236例患者(中位年龄70岁,56%为女性)接受了ERCP。从转诊到患者评估的中位时间为1.0天。从决定进行ERCP到实际操作日期的中位时间为3天。所有患者在首次操作前均进行了影像学检查。96%的患者在操作后1周内进行了血液检查。最常见的适应证与胆总管结石及其并发症有关。咪达唑仑和地西泮的平均使用剂量分别为4.4毫克和11.1毫克。选择性胆管插管率为92%。术前94%、85%和88%的患者分别成功进行了括约肌切开术、胆管支架置入术和结石完全取出术。ERCP术后发生的并发症如下:出血(1.7%)、胰腺炎(3.8%)、胆管炎(0.4%)和肾衰竭(0.4%)。30天死亡率为4.6%。然而,这些均与操作无关。
桑德兰皇家医院的ERCP服务结构为患者提供了高质量且可及的服务。技术成功率和镇静率优于BSG ERCP审核报告中的数据。并发症发生率和操作相关死亡率与BSG审核报告相当,且远低于已发表的数据。